Impact of Left Ventricular Assist Devices on Days Alive and Out of Hospital in Hemodynamically Stable Patients with End-Stage Heart Failure: A Propensity Score Matched Study

The two main surgical options to treat end-stage heart failure are heart transplantation (HTx) or left ventricular assist device (LVAD) implantation. In hemodynamically stable patients, the decision for HTx listing with or without LVADs is challenging. We analyzed the impact of both options on days...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenge, Theresa, Roth, Sebastian, M‘Pembele, René, Lurati Buse, Giovanna, Boenner, Florian, Ballázs, Christina, Tudorache, Igor, Boeken, Udo, Lichtenberg, Artur, Neukirchen, Martin, Huhn, Ragnar, Aubin, Hug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782187/
https://www.ncbi.nlm.nih.gov/pubmed/36556331
http://dx.doi.org/10.3390/life12121966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782187/
https://www.ncbi.nlm.nih.gov/pubmed/36556331
http://dx.doi.org/10.3390/life12121966

Ejemplares similares